The following discussion is an archived debate of the proposed deletion of the article below. Please do not modify it. Subsequent comments should be made on the appropriate discussion page (such as the article's
talk page or in a
deletion review). No further edits should be made to this page.
Relisted to generate a more thorough discussion and clearer consensus.
Please add new comments below this notice. Thanks,
Jenks24 (
talk) 00:47, 1 November 2017 (UTC)reply
Comment: Appears to have subsequently operated as TrialNetworks which was then acquired by
DrugDev in 2014
[1].
AllyD (
talk) 07:48, 1 November 2017 (UTC)reply
Delete: I am finding little but passing mentions (
[2] – via
HighBeam(subscription required) ). By the time of a 2010 blog they were presenting themselves on 3 fronts: "our public Epernicus Network, our Epernicus Solutions business, and Epernicus Clinical Research Systems". The first of these appears to be what was presented in the article and possibly the business re-oriented to the third, which continued for a time as TrialNetworks, but that is my speculation. I am not seeing
evidence that the attempted network under the Epernicus name attained notability, whether by
WP:NWEB or
WP:GNG.
AllyD (
talk) 08:02, 1 November 2017 (UTC)reply
The above discussion is preserved as an archive of the debate. Please do not modify it. Subsequent comments should be made on the appropriate discussion page (such as the article's
talk page or in a
deletion review). No further edits should be made to this page.
The following discussion is an archived debate of the proposed deletion of the article below. Please do not modify it. Subsequent comments should be made on the appropriate discussion page (such as the article's
talk page or in a
deletion review). No further edits should be made to this page.
Relisted to generate a more thorough discussion and clearer consensus.
Please add new comments below this notice. Thanks,
Jenks24 (
talk) 00:47, 1 November 2017 (UTC)reply
Comment: Appears to have subsequently operated as TrialNetworks which was then acquired by
DrugDev in 2014
[1].
AllyD (
talk) 07:48, 1 November 2017 (UTC)reply
Delete: I am finding little but passing mentions (
[2] – via
HighBeam(subscription required) ). By the time of a 2010 blog they were presenting themselves on 3 fronts: "our public Epernicus Network, our Epernicus Solutions business, and Epernicus Clinical Research Systems". The first of these appears to be what was presented in the article and possibly the business re-oriented to the third, which continued for a time as TrialNetworks, but that is my speculation. I am not seeing
evidence that the attempted network under the Epernicus name attained notability, whether by
WP:NWEB or
WP:GNG.
AllyD (
talk) 08:02, 1 November 2017 (UTC)reply
The above discussion is preserved as an archive of the debate. Please do not modify it. Subsequent comments should be made on the appropriate discussion page (such as the article's
talk page or in a
deletion review). No further edits should be made to this page.